The Indian Institute of Technology (IIT) Roorkee has officially released the complete syllabus for the much-anticipated JEE Advanced 2026 examination, and it is now available for direct download on ...

Aaron Levie, Co-Founder and CEO, stated that "third quarter revenue exceeded our guidance growing 9% year-over-year and producing operating margins of 28.6%." He highlighted a net retention rate of ...

Silicon Box’s recent achievement in reaching high-volume production at high yield and its commitment to open a second factory in Novara, Piedmonte, with the support of the European Commission and ...

SINGAPORE, SG / ACCESS Newswire / November 25, 2025 / Dr. Byung Joon Han, co-founder and CEO of Silicon Box attended the Bloomberg New Economy Forum (NEF) 2025, joining leaders from across 50 ...

Camizestrant combined with CDK4/6 inhibitors shows antitumor activity and is well-tolerated in patients with ER+, HER2– advanced breast cancer. The clinical benefit rate was 49.5%, with a median ...

Combining enzalutamide with standard hormone therapy cut the risk of prostate cancer death by over 40% in a clinical trial The treatment targeted patients whose prostate cancer recurred aggressively ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What's more, the drug ...

Breakthrough yield and device performance at high volume show team can scale company's large-format advanced packaging for customers' cutting-edge applications SINGAPORE, Oct. 15, 2025 /PRNewswire/ -- ...

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom ...

Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom advance, according to findings published Oct. 7 in the journal Nature Medicine ...